July 28, 2026 · Offering
ENLV Offering: a negative outcome, -47.4%
On July 28, 2026, Enlivex Therapeutics Ltd. reached its Offering. The result was a negative outcome, and the stock moved -47.4% in the window around the event. It had already run -50.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$4.26
1d before
$2.24
Event day
$2.25
1d after
$2.09
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+0.0% expected); the stock actually moved -47.4%. Model confidence at the time: 35%.
See the full scored track recordPre-catalyst setup
-50.9%
30-day run-up
7213%
30-day volatility
0.8×
volume spike